Don't be scared. It's just one little genome:
Advances in technology have made it much easier, faster and less expensive to do whole genome sequencing — to spell out all three billion letters in a person's genetic code. Falling costs have given rise to speculation that it could soon become a routine part of medical care, perhaps as routine as checking your blood pressure.
But will such tests, which can be done for as little as $1,000, prove useful, or needlessly scary?
The first closely-controlled study [DOI: 10.7326/M17-0188] [DX] aimed at answering that question suggests that doctors and their patients can handle the flood of information the tests would produce. The study was published Monday in Annals of Internal Medicine.
"We can actually do genome sequencing in normal, healthy individuals without adverse consequences — and actually with identification of some important findings," says Teri Manolio, director of the division of genomic medicine at the National Human Genome Institute, which funded the study. Manolio wrote an editorial [DOI: 10.7326/M17-1518] [DX] accompanying the paper.
(Score: 2) by Phoenix666 on Wednesday June 28 2017, @08:42PM
Pfah, no need. I know perl.
That seems a little hypothetical yet, because personalized medicine hasn't really arrived on the practitioner level. Doctor-patient confidentiality would seem to still apply, though.
Washington DC delenda est.